Depth of weight loss drug pipeline will support growth even as cost lowers, says StemPoint’s RossSeptember 24, 2024
Depth of weight loss drug pipeline will support growth even as cost lowers, says StemPoint’s RossSeptember 24, 2024
BlackRock’s Mitchnick on ETF Custody, Nasdaq Listing IBIT Options, Crypto-Stock CorrelationSeptember 24, 2024
Share Facebook Twitter LinkedIn Pinterest Email CNBC’s Deirdre Bosa joins ‘The Exchange’ to report on Anthropic’s big revenue projections for 2024, how the company is competing against established AI players, and more.